Defects in degradation of blood group A and B glycosphingolipids in Schindler and Fabry diseases

This publication has 33 references indexed in Scilit:

• Human α-N-acetylgalactosaminidase (α-NAGA) deficiency: no association with neuroaxonal dystrophy?
  European Journal of Human Genetics, 2001
• Glycoprotein lysosomal storage disorders: α- and β-mannosidosis, fucosidosis and α-N-acetylgalactosaminidase deficiency
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999
• Nomenclature of glycolipids
  Carbohydrate Research, 1998
• Blood group B glycosphingolipids in α-galactosidase deficiency (Fabry disease): influence of secretor status
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1997
• Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype.
  Journal of Medical Genetics, 1996
• Neuroaxonal Dystrophy Due to Lysosomal α-N-Acetylgalactosaminidase Deficiency
  New England Journal of Medicine, 1989
• LYSOSOMAL α-N-ACETYLGALACTOSAMINIDASE DEFICIENCY: A NEW INHERITED METABOLIC DISEASE
  The Lancet, 1987
• Hurler, Scheie, and Hurler-Scheie ‘compound’: Residual activity of α-l-iduronidase toward natural substrates suggesting allelic mutations
  Journal of Inherited Metabolic Disease, 1983
• Partial Enzyme Deficiencies: Residual Activities and the Development of Neurological Disorders
  Developmental Neuroscience, 1983
• Characterization of a Blood Group B Glycolipid, Accumulating in the Pancreas of a Patient with Fabry's Disease
  Published by Elsevier ,1973